EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 182 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $601,000 | +8485.7% | 10,000 | +7252.9% | 0.02% | – |
| Q1 2019 | $7,000 | -41.7% | 136 | -52.9% | 0.00% | -100.0% |
| Q4 2018 | $12,000 | +33.3% | 289 | +112.5% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -96.5% | 136 | -96.0% | 0.00% | -93.8% |
| Q2 2018 | $258,000 | +41.8% | 3,407 | 0.0% | 0.02% | +6.7% |
| Q4 2017 | $182,000 | -24.2% | 3,407 | -15.2% | 0.02% | -31.8% |
| Q3 2017 | $240,000 | +15.9% | 4,018 | +53.5% | 0.02% | +10.0% |
| Q2 2017 | $207,000 | -20.1% | 2,618 | -19.7% | 0.02% | -35.5% |
| Q4 2016 | $259,000 | +66.0% | 3,260 | +46.2% | 0.03% | +93.8% |
| Q3 2016 | $156,000 | +15500.0% | 2,230 | +2130.0% | 0.02% | – |
| Q3 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |